Enveric Biosciences Inc. (NASDAQ: ENVB) Stock Information | RedChip

Enveric Biosciences Inc. (NASDAQ: ENVB)


$0.3110
+0.0010 ( +2.64% ) 252.6K

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.

Market Data


Open


$0.3110

Previous close


$0.3100

Volume


252.6K

Market cap


$3.01M

Day range


$0.2950 - $0.3390

52 week range


$0.2950 - $2.9200

SEC Filings


Form Type Description Pages Date
def Proxies and info statements 3 Dec 18, 2024
pre Proxies and info statements 3 Nov 27, 2024
8-k 8K-related 13 Nov 22, 2024
10-q Quarterly Reports 63 Nov 14, 2024
8-k 8K-related 15 Nov 14, 2024
8-k 8K-related 15 Nov 12, 2024
4 Insider transactions 1 Oct 11, 2024
4 Insider transactions 1 Oct 11, 2024
4 Insider transactions 1 Oct 11, 2024
4 Insider transactions 1 Oct 11, 2024

Latest News